Vimarsana
Biggest News Aggregation in the World

Page 5 - Distinguished Practitioner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Distinguished Practitioner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Distinguished Practitioner Today - Breaking & Trending Today

The Good, the Bad and the Ugly Reality of Afghanistan - Vimarsana News

The Good, the Bad and the Ugly Reality of Afghanistan

The Cipher Daily Brief Get a daily rundown of the top security stories delivered to your inbox Monday through Friday with exclusive briefs and columns on what matters most to you and your organization. SIGN UP FOR The Free NewsletterSign up The Good, the Bad and the Ugly Reality of Afghanistan May 5, 2021 The Newsletter Cipher Brief Expert John McLaughlin served as Acting CIA Director from July to September 2004 and as Deputy Director from October 2000 to July 2004. He is the Distinguished Practitioner in Residence at the Johns Hopkins School of Advanced International Studies (SAIS). EXPERT P...

On Nuclear: Iran and North Korea are a Package Deal - Vimarsana News

On Nuclear: Iran and North Korea are a Package Deal

The Cipher Daily Brief Get a daily rundown of the top security stories delivered to your inbox Monday through Friday with exclusive briefs and columns on what matters most to you and your organization. SIGN UP FOR The Free NewsletterSign up On Nuclear: Iran and North Korea are a Package Deal April 9, 2021 | John McLaughlin The Newsletter Cipher Brief Expert John E. McLaughlin served as Acting Director of Central Intelligence from July to September 2004 and as Deputy Director of Central Intelligence from October 2000 to July 2004.  He is currently the Distinguished Practitioner in Residence ...

The Future of Navalny's Opposition Movement - Vimarsana News

The Future of Navalny's Opposition Movement

John McLaughlin served as Acting Director of Central Intelligence and as Deputy Director of Central Intelligence. He is the Distinguished Practitioner in Residence at the Johns Hopkins School of Advanced International Studies (SAIS). OPINION — The Biden administration slapped economic sanctions last week on a number of Russian officials in response to the poisoning of opposition leader Alexei Navalny in August and his imprisonment upon returning to Moscow in January after successful treatment in Germany. Navalny’s supporters met the Kremlin’s action with waves of protest, for which 4,...

Regener Eyes: First-in-Class Biologic Eye Drop Regener-Eyes Announces New Clinical Advisory Board Member Dr. Art Epstein - Vimarsana News

Regener Eyes: First-in-Class Biologic Eye Drop Regener-Eyes Announces New Clinical Advisory Board Member Dr. Art Epstein

(1) PALM HARBOR, FL / ACCESSWIRE / February 23, 2021 / Regener-Eyes ®, a leading first-in-class biologic eye drop made of naturally-occurring cytokines and growth factors, today announced the addition of Dr. Art Epstein to its Clinical Advisory Board. "We are excited to have Dr. Art Epstein join our clinical advisory board. He is a highly respected eye care professional, and will bring valuable insight to our company's efforts," commented C. Randall Harrell, M.D., CEO and Founder of Regener-Eyes ®. "We are honored to add Dr. Epstein to our existing board alongside our other impressive membe...

Biden's Big Iran Challenge - Vimarsana News

Biden's Big Iran Challenge

Cipher Brief Expert John E. McLaughlin is the Distinguished Practitioner in Residence at the Johns Hopkins School of Advanced International Studies (SAIS).  He served as Acting Director of Central Intelligence from July to September 2004 and as Deputy Director of Central Intelligence from October 2000 to July 2004. EXPERT TAKE – Getting Iran back into compliance with the 2015 agreement constraining its nuclear work will rank highly on President-elect Biden’s list of urgent foreign policy challenges. This will require untangling a web of interlocking problems left by the Trump administrat...